| Extrahepatic manifestations of chronic hepatitis C virus infection P Cacoub, L Gragnani, C Comarmond, AL Zignego Digestive and Liver Disease 46, S165-S173, 2014 | 346 | 2014 |
| Prospective study of guideline‐tailored therapy with direct‐acting antivirals for hepatitis C virus‐associated mixed cryoglobulinemia L Gragnani, M Visentini, E Fognani, T Urraro, A De Santis, L Petraccia, ... Hepatology 64 (5), 1473-1482, 2016 | 219 | 2016 |
| Long‐term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open‐label, cohort study L Gragnani, E Fognani, A Piluso, B Boldrini, T Urraro, A Fabbrizzi, C Stasi, ... Hepatology 61 (4), 1145-1153, 2015 | 145 | 2015 |
| Effect of antiviral treatment in patients with chronic HCV infection and t (14; 18) translocation F Giannelli, S Moscarella, C Giannini, P Caini, M Monti, L Gragnani, ... Blood 102 (4), 1196-1201, 2003 | 140 | 2003 |
| HCV and lymphoproliferation AL Zignego, C Giannini, L Gragnani Journal of Immunology Research 2012, 2012 | 131 | 2012 |
| Hepatitis C virus lymphotropism: lessons from a decade of studies AL Zignego, C Giannini, M Monti, L Gragnani Digestive and Liver Disease 39, S38-S45, 2007 | 119 | 2007 |
| Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection AL Zignego, L Gragnani, A Piluso, M Sebastiani, D Giuggioli, P Fallahi, ... Expert review of clinical immunology 11 (1), 15-31, 2015 | 117 | 2015 |
| International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement AL Zignego, M Ramos-Casals, C Ferri, D Saadoun, L Arcaini, ... Autoimmunity reviews 16 (5), 523-541, 2017 | 114 | 2017 |
| HERG K+ Channels Activation during β1Integrin-mediated Adhesion to Fibronectin Induces an Up-regulation of αvβ3 Integrin in the Preosteoclastic Leukemia Cell Line FLG 29.1 G Hofmann, PA Bernabei, O Crociani, A Cherubini, L Guasti, S Pillozzi, ... Journal of Biological Chemistry 276 (7), 4923-4931, 2001 | 111 | 2001 |
| Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups C Ferri, F Ursini, L Gragnani, V Raimondo, D Giuggioli, R Foti, M Caminiti, ... Journal of autoimmunity 125, 102744, 2021 | 106 | 2021 |
| Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study L Gragnani, A Fabbrizzi, E Triboli, T Urraro, B Boldrini, E Fognani, ... Digestive and Liver Disease 46 (9), 833-837, 2014 | 85 | 2014 |
| Genetic determinants in hepatitis C virus–associated mixed cryoglobulinemia: Role of polymorphic variants of BAFF promoter and Fcγ receptors L Gragnani, A Piluso, C Giannini, P Caini, E Fognani, M Monti, A Petrarca, ... Arthritis & Rheumatism 63 (5), 1446-1451, 2011 | 76 | 2011 |
| Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: phase II clinical trial and systematic review M Visentini, C Tinelli, S Colantuono, M Monti, S Ludovisi, L Gragnani, ... Autoimmunity Reviews 14 (10), 889-896, 2015 | 74 | 2015 |
| Genome-wide association study of hepatitis C virus-and cryoglobulin-related vasculitis AL Zignego, GL Wojcik, P Cacoub, M Visentini, M Casato, A Mangia, ... Genes & Immunity 15 (7), 500-505, 2014 | 67 | 2014 |
| The hepatitis C virus infection as a systemic disease AL Zignego, L Gragnani, C Giannini, G Laffi Internal and emergency medicine 7, 201-208, 2012 | 64 | 2012 |
| Virological and clinical response to interferon-free regimens in patients with HCV-related mixed cryoglobulinemia: preliminary results of a prospective pilot study L Gragnani, A Piluso, T Urraro, A Fabbrizzi, E Fognani, L Petraccia, ... Current drug targets 18 (7), 772-785, 2017 | 63 | 2017 |
| Free light chains: Eclectic multipurpose biomarker U Basile, F Gulli, L Gragnani, C Napodano, K Pocino, GL Rapaccini, ... Journal of immunological methods 451, 11-19, 2017 | 55 | 2017 |
| Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia E Fognani, C Giannini, A Piluso, L Gragnani, M Monti, P Caini, J Ranieri, ... PLoS One 8 (5), e62965, 2013 | 53 | 2013 |
| Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies GB Knight, L Gao, L Gragnani, MM Elfahal, FG De Rosa, FD Gordon, ... Arthritis & Rheumatism 62 (7), 2152-2159, 2010 | 51 | 2010 |
| Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia C Giannini, A Petrarca, M Monti, U Arena, P Caini, V Solazzo, L Gragnani, ... Blood, The Journal of the American Society of Hematology 111 (5), 2943-2945, 2008 | 47 | 2008 |
